Thursday, December 8, 2005 - 3:30 PM
158

Hepatitis B Screening in Pregnant Women and Vaccine Birth Dose Administration in Newborns: A Review from Selected Indiana Hospitals

Jennifer J. McCarthy, Charlene Graves, and Beverly Sheets.


Learning Objectives for this Presentation:
By the end of the presentation participants will be able to identify factors associated with Hepatitis B screening and the factors associated with Hepatitis B birth dose administration.

Background:
The Indiana Perinatal Hepatitis B (PHB) program is responsible for investigating reported cases of pregnant women diagnosed with Hepatitis B infection. The responsibility includes that the newborn receives HBIG, completes Hepatitis B vaccine series (including birth dose), and is tested for serologic immunity. The program works with physicians to screen all pregnant women for Hepatitis B infection, and with hospitals to implement a universal Hepatitis B vaccine birth dose policy.

Methods:
Interviews with labor-delivery nurse managers from 13 Indiana hospitals were completed; and their maternal and newborn charts from the first 6 months of 2004 assessed. A standardized survey form was used to collect data; including general demographics (no identifying information collected). Maternal records were reviewed for Rubella and Hepatitis B screening methods. Newborn charts were reviewed for Hepatitis B birth dose information and maternal Hepatitis B status. The proper reporting procedures for positive cases were also examined.

Results:
Preliminary data indicates in maternal charts that 95.1% of pregnant women were screened for Rubella compared to 96.1% for Hepatitis B. Only 39.6% of pregnant women were screened for Hepatitis B in the first trimester and 89.9% of the test results were transcribed. For newborns, only 69.4% received the Hepatitis B birth dose. Only 13% of charts had evidence that the VIS was provided properly. 81.7% of the newborn charts had a maternal Hepatitis B screening result, of which 99.4% were transcribed.

Conclusions:
Additional record reviews are planned to determine if the same trends occur in all 92 delivering hospitals. The PHB program will update and continue to promote correct screening procedures. The birth dose policy will be addressed as part of the state's Viral Hepatitis Strategic Plan.

See more of I1 - Hospital Based Assessment of Hepatitis B Screening of Pregnant Women
See more of The 2005 National Viral Hepatitis Prevention Conference